首页 > 最新文献

Proteomics最新文献

英文 中文
Issue Information: Proteomics 11–12'25 出版信息:Proteomics 11-12 '25
IF 3.9 4区 生物学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-06-27 DOI: 10.1002/pmic.70002
{"title":"Issue Information: Proteomics 11–12'25","authors":"","doi":"10.1002/pmic.70002","DOIUrl":"10.1002/pmic.70002","url":null,"abstract":"","PeriodicalId":224,"journal":{"name":"Proteomics","volume":"25 11-12","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pmic.70002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144503145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond Gravity: Leveraging Gene Plasticity to Mitigate Spaceflight-Induced Pathologies 超越重力:利用基因可塑性来减轻太空飞行引起的病理
IF 3.9 4区 生物学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-06-27 DOI: 10.1002/pmic.202500087
Irina-Mihaela Matache

As space exploration becomes increasingly accessible, understanding the molecular and pathophysiological consequences of spaceflight on the human body becomes crucial. Space-induced modifications could disrupt multiple signaling pathways, with significant implications for the functional integrity of cardiovascular, nervous, and musculoskeletal systems, among others. In a recent study, Bourdakou et al. have focused on alterations in gene expression profiles linked to cardiovascular disease (CVD), using human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) undergoing spaceflight and subsequent postflight conditions. Genes with known associations with CVD and nuclear factor erythroid 2-related factor 2 (NRF2) oxidative stress regulatory network have been identified to present consistent directional expression changes in both spaceflight and postflight. A computational drug repurposing analysis identified ten candidate agents with the potential to reverse observed transcriptomic modifications in spaceflight-exposed cardiomyocytes. These findings highlight the importance of molecular studies and emphasize the need for integrative, multi-omic research efforts to protect human health during and beyond spaceflight.

随着太空探索变得越来越容易,了解太空飞行对人体的分子和病理生理后果变得至关重要。空间诱导的改变可能会破坏多种信号通路,对心血管、神经和肌肉骨骼系统等的功能完整性产生重大影响。在最近的一项研究中,Bourdakou等人利用人类诱导多能干细胞衍生的心肌细胞(hiPSC-CMs)进行了航天飞行和随后的飞行后条件,重点研究了与心血管疾病(CVD)相关的基因表达谱的改变。已知与CVD和核因子-红细胞2相关因子2 (NRF2)氧化应激调控网络相关的基因在航天飞行和飞行后均呈现一致的定向表达变化。一项计算药物再利用分析确定了10种候选药物,它们有可能逆转太空飞行暴露的心肌细胞中观察到的转录组修饰。这些发现突出了分子研究的重要性,并强调需要开展综合、多组学研究工作,以在航天飞行期间和之后保护人类健康。
{"title":"Beyond Gravity: Leveraging Gene Plasticity to Mitigate Spaceflight-Induced Pathologies","authors":"Irina-Mihaela Matache","doi":"10.1002/pmic.202500087","DOIUrl":"10.1002/pmic.202500087","url":null,"abstract":"<p>As space exploration becomes increasingly accessible, understanding the molecular and pathophysiological consequences of spaceflight on the human body becomes crucial. Space-induced modifications could disrupt multiple signaling pathways, with significant implications for the functional integrity of cardiovascular, nervous, and musculoskeletal systems, among others. In a recent study, Bourdakou et al. have focused on alterations in gene expression profiles linked to cardiovascular disease (CVD), using human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) undergoing spaceflight and subsequent postflight conditions. Genes with known associations with CVD and nuclear factor erythroid 2-related factor 2 (NRF2) oxidative stress regulatory network have been identified to present consistent directional expression changes in both spaceflight and postflight. A computational drug repurposing analysis identified ten candidate agents with the potential to reverse observed transcriptomic modifications in spaceflight-exposed cardiomyocytes. These findings highlight the importance of molecular studies and emphasize the need for integrative, multi-omic research efforts to protect human health during and beyond spaceflight.</p>","PeriodicalId":224,"journal":{"name":"Proteomics","volume":"25 11-12","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pmic.202500087","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144503147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-Disciplinary and Omics-Driven Approaches to Advance Personalized Medicine in Cardiovascular and Chronic Kidney Disease 多学科和组学驱动的方法推进心血管和慢性肾脏疾病的个性化医疗
IF 3.9 4区 生物学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-06-27 DOI: 10.1002/pmic.202500093
Griet Glorieux, Julie Klein, Agnieszka Latosinska
<p>We are living in an omics era, in which molecular profiling technologies can detect thousands of molecules across multiple biological layers. Yet chronic diseases—such as chronic kidney disease (CKD) and cardiovascular disease (CVD)—are still diagnosed only after overt signs and symptoms appear, relying on biomarkers that indicate established organ damage (e.g., estimated glomerular filtration rate (eGFR), albuminuria, troponin T, natriuretic peptides) [<span>1</span>]. In other words, by the time a chronic disease is recognized, curative treatment is generally no longer possible, as irreversible organ damage has already occurred. These conditions are termed “chronic” because, once they develop, patients live with them for the rest of their lives. Additionally, their life expectancy is shorter with a significant loss of quality of life.</p><p>Preventive measures to reduce the global burden of chronic diseases are therefore of paramount importance. The impact is enormous: in 2021, CKD caused 1.5 million deaths [<span>2</span>], while CVD accounted for more than 20 million deaths [<span>3</span>], with ischemic heart disease the leading and CKD the eleventh leading cause of mortality worldwide. Disability-adjusted life-years (DALYs) totaled 212 million for ischemic heart disease and 44.5 million for CKD [<span>4</span>]. In addition, the economic impact of both CKD and CVD is huge and is estimated to further increase in the coming years [<span>5-7</span>]. However, diagnosed cases represent only the “tip of the iceberg” (Figure 1); most patients remain undiagnosed because these diseases develop silently and progressively over the years.</p><p>CKD and CVD originate at the molecular level (bottom of the iceberg), are tightly interconnected—each increasing the risk of the other—and share common risk factors such as diabetes and hypertension. Additionally, therapies overlap for example, in patients with established CKD, renin–angiotensin system inhibitors, sodium-glucose co-transporter 2 inhibitors, and the non-steroidal mineralocorticoid receptor agonist finerenone reduce not only the risk of kidney disease progression but also cardiovascular events [<span>3</span>]. Considering the continuum of disease development, it is logical to intervene as early as possible, when the disease-associated changes are only at the molecular level. Moreover, early intervention has been demonstrated to be the most effective approach. In fact, intervention before irreversible organ damage should ideally even prevent onset of chronic disease. At the same time, no single biomarker can capture the complexity of these systemic disorders, which involve multiple organs and show marked heterogeneity in progression and treatment response. The societal, healthcare, and economic burden of CKD and CVD underscores the need for personalized, omics-based approaches that accommodate this multifactorial complexity and enable personalized intervention.</p><p>Personalized medicine rep
我们生活在一个组学时代,在这个时代,分子分析技术可以在多个生物层中检测到数千个分子。然而,慢性疾病,如慢性肾病(CKD)和心血管疾病(CVD),仍然只能在出现明显的体征和症状后才能诊断,依赖于指示已确定的器官损伤的生物标志物(例如,估计的肾小球滤过率(eGFR)、蛋白尿、肌钙蛋白T、利钠肽)[1]。换句话说,当一种慢性疾病被确诊时,由于已经发生了不可逆转的器官损伤,治愈性治疗通常已经不可能了。这些疾病被称为“慢性”,因为一旦发病,患者将伴随其一生。此外,他们的预期寿命更短,生活质量显著下降。因此,减少全球慢性病负担的预防措施至关重要。影响是巨大的:2021年,CKD造成150万人死亡,而CVD造成2000多万人死亡,其中缺血性心脏病是全球第一大死亡原因,CKD是第11大死亡原因。缺血性心脏病的残疾调整生命年(DALYs)为2.12亿,CKD为4450万。此外,CKD和CVD的经济影响都是巨大的,预计未来几年将进一步增加[5-7]。然而,确诊病例仅代表“冰山一角”(图1);大多数患者仍未得到诊断,因为这些疾病是悄无声息地、多年来逐渐发展的。CKD和CVD起源于分子水平(冰山底部),它们紧密相连——每一种都增加了另一种的风险——并且有共同的风险因素,如糖尿病和高血压。此外,治疗重叠,例如,在已确定的CKD患者中,肾素-血管紧张素系统抑制剂、钠-葡萄糖共转运蛋白2抑制剂和非甾体矿物皮质激素受体激动剂芬纳酮不仅可以降低肾脏疾病进展的风险,还可以降低心血管事件的风险。考虑到疾病发展的连续性,当疾病相关的变化仅在分子水平上时,尽早干预是合乎逻辑的。此外,早期干预已被证明是最有效的方法。事实上,在不可逆器官损伤之前进行干预,理想情况下甚至可以预防慢性疾病的发生。同时,没有单一的生物标志物可以捕捉到这些系统性疾病的复杂性,这些疾病涉及多个器官,在进展和治疗反应方面表现出明显的异质性。CKD和CVD的社会、医疗和经济负担强调了个性化、基于组学的方法的需求,以适应这种多因素复杂性并实现个性化干预。个性化医疗通过根据每个人的生物特征定制预防、诊断和治疗,代表了医疗保健领域的重大转变。这得益于组学技术、数据处理、分析工具和人工智能(AI)的进步。通过整合多层分子数据,可以更精确地表征疾病,并在临床症状出现之前发现疾病,从而实现更早、更有针对性的干预。这种方法已经在肿瘤学中得到了很好的应用,其中有几种治疗方法与肿瘤分子谱相匹配。为此,PerMediK项目成立,这是一项欧洲研究计划,致力于加速CKD和CVD个性化医疗的开发和临床实施。它促进了组学科学、计算生物学和临床研究之间的跨学科合作,支持生物标志物发现、治疗靶向和患者分层方面的创新,并强调了医疗保健领域的数据集成、可再现性和公平性。这期特刊题为《组学在心血管和肾脏疾病的个性化管理》,致力于探索组学和计算方法的应用,以更好地以个性化的方式了解和管理CKD和CVD。这些贡献跨越了从基础科学到转化和临床应用的连续体,突出了个性化医学在慢性疾病管理中的变革潜力,总结如下。Rroji等人、Beige等人和Lopes等人各自对多组学和计算方法如何改变慢性疾病管理贡献了不同但互补的观点[9-11]。Rroji等人建立了个体化医疗的案例,概述了集成多组学和机器学习模型如何克服传统标志物(如eGFR和蛋白尿)的局限性,从而实现CKD bb0的早期风险预测和个性化治疗策略。米色等人。 提出基于临床的观点,提倡将尿蛋白质组学纳入常规护理,特别是在早期疾病检测和指导CKD和心血管合并症的无创管理方面。Lopes等人提出了将组学数据集与机器学习方法相结合的路线图,以支持CKD的早期诊断、风险预测和具有成本效益的个性化治疗。他们不仅强调了监督和无监督机器学习模型的技术进步,还强调了临床前验证、健康经济评估和跨学科合作在将这些工具转化为实践中的关键重要性。这些贡献共同强调了将技术创新与临床需求结合起来的重要性,并强调了组学在改善复杂慢性疾病护理轨迹方面的潜力。与此同时,研究结果的实施应向前推进,最终使社会受益。尿肽组学是这一问题的基石,目前是一种公认的强大的非侵入性方法来评估肾脏和心血管健康。本系列中的几项研究举例说明了如何利用尿肽谱分析来探索人群水平的风险和疾病的机制见解。在一项大型的多种族研究中,An等人阐述了尿肽谱分析如何能够提供人群水平的见解,确定了8种蛋白质,这些蛋白质可能是黑人和白人人群对盐敏感性和高血压相关并发症易感性差异的基础[10]。这项工作强调了包容性组学研究在了解人群特异性疾病风险方面的重要性。纤维化,CKD的标志,是尿肽组学被证明具有高度信息性的另一个领域。Martin等人证明了III型胶原降解产生的尿肽,包括基于抗体的C3M测定的靶向序列,与肾功能下降和纤维化[13]相关。Mina等人将这项研究扩展到I型胶原降解,提出了一个逐步分解过程的模型,以及降解受损在疾病进展中的潜在作用[14]。总之,这些研究强调了尿肽组学通过蛋白质降解来评估疾病的诊断和机制价值,蛋白质降解是纤维化中一个特别相关但尚未得到充分研究的成分。尿液为肾脏特异性过程提供了一个直接的窗口,在某种程度上,由于其起源于血液的肾小球滤过,血浆为全身变化提供了一个更广阔的视角,特别是与心血管系统相关的变化。为了捕获这些系统特征,Fernandez等人开发并验证了血浆肽组学[15]的强大CE-MS管道。这种方法补充了尿谱分析,可以更直接、更详细地了解炎症、凝血和其他CKD和CVD中关键的血管过程。Fernandez等人的研究还举例说明了健壮、标准化工作流程的重要性,特别是在组学技术不断发展并产生越来越复杂的数据集的情况下。建立这种方法的一致性是确保可重复性和支持后续临床实施的关键。超越传统模型,Bourdakou等人提出了一项引人注目的系统生物学研究,该研究利用暴露于航天条件下的人类诱导多能干细胞衍生的心肌细胞的基因表达数据。他们的发现暗示了氧化应激和核因子-红细胞2相关因子2 (NRF2)信号在心血管功能障碍中的作用,并且他们的整合管道确定了潜在的可重复利用的药物。这种独特的方法强调了组学驱动的翻译工具如何为疾病机制和治疗机会提供信息,即使在非常规环境中也是如此。García-Sáez等人通过比较不同物种[17]的分子特征进一步拓展了组学的翻译潜力。他们的工作旨在提高临床前模型的可靠性,从而提高研究结果在应用于人类疾病时的相关性和可预测性。寻找新的治疗策略是本期特刊的另一个高度相关的焦点。药物再利用是为现有药物寻找新的治疗用途的一种成本效益高、时间效率高的方法。Perco等人提供了计算药物重新定位在心肾疾病[18]的全面概述。他们的观点概述了组学衍生的特征、蛋白质网络和机器学习如何揭示新的药物-疾病关系。Bourdakou等人通过展示这些方法的另一种实际应用来补充这一观点,以确定航天飞行引起的应激bb0后的心血管候选药物。 总之,这些研究突出了利用组学驱动的见解利用现有药物治疗新适应症的效率和前景,这是治疗复杂疾病的一种非常重要的方法。没有对伦理、法律和社会影响的关注,任何个性化医疗努力都是不完整的。azsamma等人通过他们在肾脏设计项目中的工作探索了这一维度,呼吁患者、伦理学家和多学科利益相关者在研究过
{"title":"Multi-Disciplinary and Omics-Driven Approaches to Advance Personalized Medicine in Cardiovascular and Chronic Kidney Disease","authors":"Griet Glorieux,&nbsp;Julie Klein,&nbsp;Agnieszka Latosinska","doi":"10.1002/pmic.202500093","DOIUrl":"10.1002/pmic.202500093","url":null,"abstract":"&lt;p&gt;We are living in an omics era, in which molecular profiling technologies can detect thousands of molecules across multiple biological layers. Yet chronic diseases—such as chronic kidney disease (CKD) and cardiovascular disease (CVD)—are still diagnosed only after overt signs and symptoms appear, relying on biomarkers that indicate established organ damage (e.g., estimated glomerular filtration rate (eGFR), albuminuria, troponin T, natriuretic peptides) [&lt;span&gt;1&lt;/span&gt;]. In other words, by the time a chronic disease is recognized, curative treatment is generally no longer possible, as irreversible organ damage has already occurred. These conditions are termed “chronic” because, once they develop, patients live with them for the rest of their lives. Additionally, their life expectancy is shorter with a significant loss of quality of life.&lt;/p&gt;&lt;p&gt;Preventive measures to reduce the global burden of chronic diseases are therefore of paramount importance. The impact is enormous: in 2021, CKD caused 1.5 million deaths [&lt;span&gt;2&lt;/span&gt;], while CVD accounted for more than 20 million deaths [&lt;span&gt;3&lt;/span&gt;], with ischemic heart disease the leading and CKD the eleventh leading cause of mortality worldwide. Disability-adjusted life-years (DALYs) totaled 212 million for ischemic heart disease and 44.5 million for CKD [&lt;span&gt;4&lt;/span&gt;]. In addition, the economic impact of both CKD and CVD is huge and is estimated to further increase in the coming years [&lt;span&gt;5-7&lt;/span&gt;]. However, diagnosed cases represent only the “tip of the iceberg” (Figure 1); most patients remain undiagnosed because these diseases develop silently and progressively over the years.&lt;/p&gt;&lt;p&gt;CKD and CVD originate at the molecular level (bottom of the iceberg), are tightly interconnected—each increasing the risk of the other—and share common risk factors such as diabetes and hypertension. Additionally, therapies overlap for example, in patients with established CKD, renin–angiotensin system inhibitors, sodium-glucose co-transporter 2 inhibitors, and the non-steroidal mineralocorticoid receptor agonist finerenone reduce not only the risk of kidney disease progression but also cardiovascular events [&lt;span&gt;3&lt;/span&gt;]. Considering the continuum of disease development, it is logical to intervene as early as possible, when the disease-associated changes are only at the molecular level. Moreover, early intervention has been demonstrated to be the most effective approach. In fact, intervention before irreversible organ damage should ideally even prevent onset of chronic disease. At the same time, no single biomarker can capture the complexity of these systemic disorders, which involve multiple organs and show marked heterogeneity in progression and treatment response. The societal, healthcare, and economic burden of CKD and CVD underscores the need for personalized, omics-based approaches that accommodate this multifactorial complexity and enable personalized intervention.&lt;/p&gt;&lt;p&gt;Personalized medicine rep","PeriodicalId":224,"journal":{"name":"Proteomics","volume":"25 11-12","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pmic.202500093","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144503146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantitative Proteomics of Cochlear Tissues: Bilateral Comparisons in Guinea Pigs and Rats 耳蜗组织的定量蛋白质组学:豚鼠和大鼠的双边比较。
IF 3.9 4区 生物学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-06-23 DOI: 10.1002/pmic.13977
Motahare Khorrami, Paul A. Haynes, Christopher Pastras, Mohsen Asadnia

The cochlea, an incredibly sensitive sensory system, detects sound waves and converts them into electrical signals the brain recognizes as sound. Damage to cochlear hair cells can release proteins, triggering biological responses that may impair hearing. Mass spectrometry-based proteomics offers insights into protein expression changes in cochlear tissues, improving our understanding of inner ear diseases. In this study, we performed a comprehensive proteomics analysis of whole cochlear tissue extracted from healthy guinea pigs and rats. The study optimized protein extraction protocols and analyzed cochlear protein expression using three biological replicates for each animal model. The results included the identification of 1841 proteins in guinea pigs and 3423 proteins in rats, with a high overlap in cochlear protein expression between the left and right ears—93% in guinea pigs and 89% in rats. The findings validate the assumption that the cochlear tissues from both sides of the ears can be considered biologically equivalent. This experiment provides a comprehensive cochlear proteome for guinea pigs and rats, supporting future studies on inner ear disorders.

耳蜗是一种非常敏感的感觉系统,它能探测到声波并将其转化为大脑识别为声音的电信号。耳蜗毛细胞受损会释放蛋白质,引发可能损害听力的生物反应。基于质谱的蛋白质组学提供了耳蜗组织中蛋白质表达变化的见解,提高了我们对内耳疾病的理解。在这项研究中,我们对健康豚鼠和大鼠的全耳蜗组织进行了全面的蛋白质组学分析。该研究优化了蛋白质提取方案,并对每种动物模型使用三个生物重复分析耳蜗蛋白表达。结果包括在豚鼠中鉴定出1841种蛋白,在大鼠中鉴定出3423种蛋白,左耳和右耳之间耳蜗蛋白表达高度重叠,豚鼠为93%,大鼠为89%。研究结果证实了一个假设,即耳朵两侧的耳蜗组织在生物学上是等同的。本实验为豚鼠和大鼠提供了一个全面的耳蜗蛋白质组,为未来内耳疾病的研究提供了支持。
{"title":"Quantitative Proteomics of Cochlear Tissues: Bilateral Comparisons in Guinea Pigs and Rats","authors":"Motahare Khorrami,&nbsp;Paul A. Haynes,&nbsp;Christopher Pastras,&nbsp;Mohsen Asadnia","doi":"10.1002/pmic.13977","DOIUrl":"10.1002/pmic.13977","url":null,"abstract":"<p>The cochlea, an incredibly sensitive sensory system, detects sound waves and converts them into electrical signals the brain recognizes as sound. Damage to cochlear hair cells can release proteins, triggering biological responses that may impair hearing. Mass spectrometry-based proteomics offers insights into protein expression changes in cochlear tissues, improving our understanding of inner ear diseases. In this study, we performed a comprehensive proteomics analysis of whole cochlear tissue extracted from healthy guinea pigs and rats. The study optimized protein extraction protocols and analyzed cochlear protein expression using three biological replicates for each animal model. The results included the identification of 1841 proteins in guinea pigs and 3423 proteins in rats, with a high overlap in cochlear protein expression between the left and right ears—93% in guinea pigs and 89% in rats. The findings validate the assumption that the cochlear tissues from both sides of the ears can be considered biologically equivalent. This experiment provides a comprehensive cochlear proteome for guinea pigs and rats, supporting future studies on inner ear disorders.</p>","PeriodicalId":224,"journal":{"name":"Proteomics","volume":"25 13","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pmic.13977","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144367640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Defining the Molecular Impacts of Humalite Application on Field-Grown Wheat (Triticum aestivum L.) Using Quantitative Proteomics 确定在大田小麦(Triticum aestivum L.)上施用腐殖石的分子效应使用定量蛋白质组学。
IF 3.9 4区 生物学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-06-23 DOI: 10.1002/pmic.13981
Lauren E. Grubb, Mohana Talasila, Linda Y. Gorim, Richard Glen Uhrig

Increasing global food production demands have resulted in increased fertilizer usage, causing detrimental environmental impacts. Biostimulants, such as humic substances, are currently being applied as a strategy to increase plant nutrient-use efficiency and minimize environmental impacts within cropping systems. One of these biostimulants is Humalite, which is a unique, naturally occurring coal-like substance found in deposits across southern Alberta. These deposits contain exceptionally high ratios of humic acids (>70%) and micronutrients due to their unique freshwater depositional environment. Humalite has begun to be applied to fields based on scientific data suggesting positive impacts on crop growth, yield, and nutrient usage; however, little is known about the underlying molecular mechanisms of Humalite. Here, as part of a larger field study, we report a quantitative proteomics approach to identify systems-level molecular changes induced by the addition of different Humalite application rates in field-grown wheat (Triticum aestivum L.) under three urea fertilizer application rates. In particular, we see wide-ranging abundance changes in proteins associated with several metabolic pathways and growth-related biological processes that suggest how Humalite modulates the plant molecular landscape. Overall, our results provide new, functional information that will help better inform agricultural producers on optimal biostimulant and fertilizer usage.

全球粮食生产需求的增加导致化肥使用量的增加,造成有害的环境影响。生物刺激剂,如腐殖质物质,目前正在作为一种策略来提高作物系统内植物养分利用效率和尽量减少对环境的影响。其中一种生物刺激物是Humalite,这是一种独特的,天然存在的类似煤的物质,在阿尔伯塔省南部的矿床中发现。由于其独特的淡水沉积环境,这些沉积物含有异常高的腐植酸比率(约70%)和微量营养素。根据科学数据显示,Humalite对作物生长、产量和养分利用有积极影响,已开始在田间应用;然而,对Humalite的潜在分子机制知之甚少。在此,作为一项更大规模的田间研究的一部分,我们报告了一种定量蛋白质组学方法,以确定在三种尿素施用量下,大田小麦(Triticum aestivum L.)添加不同Humalite施用量所引起的系统级分子变化。特别是,我们看到与几种代谢途径和生长相关的生物过程相关的蛋白质的广泛丰度变化,这表明Humalite如何调节植物分子景观。总的来说,我们的研究结果提供了新的、功能性的信息,将有助于更好地告知农业生产者最佳的生物刺激素和肥料使用。
{"title":"Defining the Molecular Impacts of Humalite Application on Field-Grown Wheat (Triticum aestivum L.) Using Quantitative Proteomics","authors":"Lauren E. Grubb,&nbsp;Mohana Talasila,&nbsp;Linda Y. Gorim,&nbsp;Richard Glen Uhrig","doi":"10.1002/pmic.13981","DOIUrl":"10.1002/pmic.13981","url":null,"abstract":"<p>Increasing global food production demands have resulted in increased fertilizer usage, causing detrimental environmental impacts. Biostimulants, such as humic substances, are currently being applied as a strategy to increase plant nutrient-use efficiency and minimize environmental impacts within cropping systems. One of these biostimulants is Humalite, which is a unique, naturally occurring coal-like substance found in deposits across southern Alberta. These deposits contain exceptionally high ratios of humic acids (&gt;70%) and micronutrients due to their unique freshwater depositional environment. Humalite has begun to be applied to fields based on scientific data suggesting positive impacts on crop growth, yield, and nutrient usage; however, little is known about the underlying molecular mechanisms of Humalite. Here, as part of a larger field study, we report a quantitative proteomics approach to identify systems-level molecular changes induced by the addition of different Humalite application rates in field-grown wheat (<i>Triticum aestivum</i> L.) under three urea fertilizer application rates. In particular, we see wide-ranging abundance changes in proteins associated with several metabolic pathways and growth-related biological processes that suggest how Humalite modulates the plant molecular landscape. Overall, our results provide new, functional information that will help better inform agricultural producers on optimal biostimulant and fertilizer usage.</p>","PeriodicalId":224,"journal":{"name":"Proteomics","volume":"25 14","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pmic.13981","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144367638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Covalent Inhibition of the Peptidyl-Prolyl Isomerase Pin1 by Sulfopin Results in a Broad Impact on the Phosphoproteome of Human Osteosarcoma U2-OS Cells 磺胺对肽基脯氨酸异构酶Pin1的共价抑制对人骨肉瘤U2-OS细胞磷酸化蛋白组的广泛影响
IF 3.9 4区 生物学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-06-23 DOI: 10.1002/pmic.13980
Scott E. Roffey, Owen Hovey, Kristina Jurcic, Kun Ping Lu, Xiao Zhen Zhou, David W. Litchfield
<div> <section> <p>Peptidyl-prolyl isomerase, NIMA-interacting protein 1-(Pin1) catalyses the <i>cis</i>–<i>trans</i> interconversion of the inflexible bond between serine or threonine residues and proline at the +1 position (pSer/pThr-Pro). Although initially discovered as an essential regulator of cell division, Pin1 has since been identified as a regulator of many biological processes and is associated with numerous malignancies and neurodegenerative disorders. Pin1 has been shown to influence phosphorylation by modulating phosphatase accessibility. However, it can also indirectly regulate phosphorylation by isomerizing peptidyl-prolyl bonds on kinases, affecting their subcellular localization and/or substrate specificity. Here, SILAC-based mass spectrometry was employed to identify proteomic and phosphoproteomic changes in human osteosarcoma human osteosarcoma cell line (U2-OS) cells in response to treatment with the selective covalent Pin1 inhibitor Sulfopin. We confirmed that Sulfopin covalently binds Pin1 and profiled Pin1-dependent changes to the proteome and phosphoproteome, identifying 803 phosphosites that underwent significant Sulfopin-dependent changes. The identified phosphosites include substrates for a number of distinct kinases, including protein kinase B (AKT1), aurora kinase A (AURKA), cyclin-dependent kinase (CDK)1 and CK2. Overall, this study reveals the broad impact of Sulfopin on the phosphoproteome, improving our understanding of how Pin1 modulates complex regulatory kinase networks in living cells.</p> </section> <section> <h3> Summary</h3> <div> <ul> <li> <p>The peptidyl-prolyl isomerase (PPIase) Pin1 has emerged as a potential therapeutic target for numerous malignancies and neurodegenerative disorders based on its altered expression in several diseases.</p> </li> <li> <p>As the activity of Pin1 is phosphorylation-dependent, it is intimately involved with constituents of regulatory kinase networks within cells.</p> </li> <li> <p>To elucidate how Pin1 orchestrates regulatory signalling within cells, we performed quantitative proteomic and phosphoproteomic profiling of SILAC-labelled human osteosarcoma U2-OS cells treated with Sulfopin, a highly selective covalent Pin1 inhibitor.</p> </li> <li> <p>In addition to demonstrating that Pin1 inhibition alters the abundance and phosphorylation of proteins involved in a variety of fundamental cellular processes, these studies revealed that Pin1 inhibition modulates the
肽基脯氨酸异构酶,nima相互作用蛋白1-(Pin1)催化丝氨酸或苏氨酸残基与+1位脯氨酸(pSer/pThr-Pro)之间的不灵活键的顺-反式相互转化。尽管最初发现Pin1是细胞分裂的重要调节因子,但此后Pin1已被确定为许多生物过程的调节因子,并与许多恶性肿瘤和神经退行性疾病有关。Pin1已被证明通过调节磷酸酶的可及性来影响磷酸化。然而,它也可以通过异构化激酶上的肽-脯氨酸键间接调节磷酸化,影响其亚细胞定位和/或底物特异性。在这里,基于silac的质谱法被用于鉴定人类骨肉瘤细胞系(U2-OS)细胞在选择性共价Pin1抑制剂磺胺硫平治疗后的蛋白质组学和磷酸化蛋白质组学变化。我们证实了磺胺嘧啶与Pin1共价结合,并分析了蛋白质组和磷酸化蛋白质组中Pin1依赖性的变化,鉴定出803个磷酸化位点发生了显著的磺胺嘧啶依赖性变化。鉴定的磷酸化位点包括许多不同激酶的底物,包括蛋白激酶B (AKT1)、极光激酶a (AURKA)、细胞周期蛋白依赖性激酶(CDK)1和CK2。总的来说,本研究揭示了巯基蛋白对磷酸化蛋白质组的广泛影响,提高了我们对Pin1如何调节活细胞中复杂的调节激酶网络的理解。摘要:肽基脯氨酸异构酶(PPIase) Pin1已成为许多恶性肿瘤和神经退行性疾病的潜在治疗靶点,基于其在几种疾病中的表达改变。由于Pin1的活性是磷酸化依赖性的,它与细胞内调节激酶网络的成分密切相关。为了阐明Pin1如何协调细胞内的调节信号,我们对silac标记的人骨肉瘤U2-OS细胞进行了定量蛋白质组学和磷酸化蛋白质组学分析,这些细胞使用高选择性共价Pin1抑制剂磺胺吡啶(Sulfopin)处理。除了证明Pin1抑制改变了参与多种基本细胞过程的蛋白质的丰度和磷酸化外,这些研究还揭示了Pin1抑制调节803个磷酸化位点的磷酸化,最终提高了我们对PPIase如何调节复杂生物系统中磷酸化网络的理解。
{"title":"Covalent Inhibition of the Peptidyl-Prolyl Isomerase Pin1 by Sulfopin Results in a Broad Impact on the Phosphoproteome of Human Osteosarcoma U2-OS Cells","authors":"Scott E. Roffey,&nbsp;Owen Hovey,&nbsp;Kristina Jurcic,&nbsp;Kun Ping Lu,&nbsp;Xiao Zhen Zhou,&nbsp;David W. Litchfield","doi":"10.1002/pmic.13980","DOIUrl":"10.1002/pmic.13980","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;p&gt;Peptidyl-prolyl isomerase, NIMA-interacting protein 1-(Pin1) catalyses the &lt;i&gt;cis&lt;/i&gt;–&lt;i&gt;trans&lt;/i&gt; interconversion of the inflexible bond between serine or threonine residues and proline at the +1 position (pSer/pThr-Pro). Although initially discovered as an essential regulator of cell division, Pin1 has since been identified as a regulator of many biological processes and is associated with numerous malignancies and neurodegenerative disorders. Pin1 has been shown to influence phosphorylation by modulating phosphatase accessibility. However, it can also indirectly regulate phosphorylation by isomerizing peptidyl-prolyl bonds on kinases, affecting their subcellular localization and/or substrate specificity. Here, SILAC-based mass spectrometry was employed to identify proteomic and phosphoproteomic changes in human osteosarcoma human osteosarcoma cell line (U2-OS) cells in response to treatment with the selective covalent Pin1 inhibitor Sulfopin. We confirmed that Sulfopin covalently binds Pin1 and profiled Pin1-dependent changes to the proteome and phosphoproteome, identifying 803 phosphosites that underwent significant Sulfopin-dependent changes. The identified phosphosites include substrates for a number of distinct kinases, including protein kinase B (AKT1), aurora kinase A (AURKA), cyclin-dependent kinase (CDK)1 and CK2. Overall, this study reveals the broad impact of Sulfopin on the phosphoproteome, improving our understanding of how Pin1 modulates complex regulatory kinase networks in living cells.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Summary&lt;/h3&gt;\u0000 \u0000 &lt;div&gt;\u0000 &lt;ul&gt;\u0000 \u0000 &lt;li&gt;\u0000 &lt;p&gt;The peptidyl-prolyl isomerase (PPIase) Pin1 has emerged as a potential therapeutic target for numerous malignancies and neurodegenerative disorders based on its altered expression in several diseases.&lt;/p&gt;\u0000 &lt;/li&gt;\u0000 \u0000 &lt;li&gt;\u0000 &lt;p&gt;As the activity of Pin1 is phosphorylation-dependent, it is intimately involved with constituents of regulatory kinase networks within cells.&lt;/p&gt;\u0000 &lt;/li&gt;\u0000 \u0000 &lt;li&gt;\u0000 &lt;p&gt;To elucidate how Pin1 orchestrates regulatory signalling within cells, we performed quantitative proteomic and phosphoproteomic profiling of SILAC-labelled human osteosarcoma U2-OS cells treated with Sulfopin, a highly selective covalent Pin1 inhibitor.&lt;/p&gt;\u0000 &lt;/li&gt;\u0000 \u0000 &lt;li&gt;\u0000 &lt;p&gt;In addition to demonstrating that Pin1 inhibition alters the abundance and phosphorylation of proteins involved in a variety of fundamental cellular processes, these studies revealed that Pin1 inhibition modulates the ","PeriodicalId":224,"journal":{"name":"Proteomics","volume":"25 14","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/pmic.13980","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144367637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metaproteomic Dataset on Semi-Diurnal Variability of the Bacterioplankton Communities During a Spring Phytoplankton Bloom in the North Sea 北海春季浮游植物繁殖期间浮游细菌群落半日变化的元蛋白质组学数据集。
IF 3.9 4区 生物学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-06-23 DOI: 10.1002/pmic.70001
Vaikhari Kale, Jürgen Bartel, Daniel Bartosik, Philip Berhard Lude, Chandni Sidhu, Hanno Teeling, Rudolf Amann, Thomas Schweder, Dörte Becher, Anke Trautwein-Schult

Phytoplankton blooms create a substrate-rich environment that supports the growth of bacterial planktonic heterotrophs. Previously, we studied the dynamics of such bacterioplankton at a long-term ecological research site near the coast of Helgoland Island (North Sea) once a day. Here, we present a novel dataset (available under the PRIDE-ID: PXD055396) indicating significant differences at the protein level in a semi-diurnal analysis. Using metaproteomics, we studied changes in the free-living (0.2–3 µm) bacterial community that occurred between early (7 am) and late (9 pm) sampling over 3 days. The results highlight the sensitivity, robustness, and reproducibility of mass spectrometry-based metaproteomic analyses to assess changes in the activities of the bacterioplankton communities. Taxonomic analyses revealed significant changes in the abundance of 65 bacterial genera. Particularly, proteins from the flavobacterial genera Candidatus Prosiliicoccus and Aurantivirga were significantly more abundant in the late samples. This comprehensive dataset highlights semi-diurnal changes in bacterial community composition and metabolic activity during a phytoplankton bloom that would have remained undetected with a once-per-day sampling approach.

浮游植物的大量繁殖创造了一个富含基质的环境,支持细菌浮游异养生物的生长。在此之前,我们每天一次在北海Helgoland岛海岸附近的一个长期生态研究点研究这些浮游细菌的动态。在这里,我们提出了一个新的数据集(在PRIDE-ID: PXD055396下可用),表明在半昼夜分析中蛋白质水平存在显著差异。使用宏蛋白质组学,我们研究了3天内早(早上7点)和晚(晚上9点)采样期间自由生活(0.2-3µm)细菌群落的变化。这些结果突出了基于质谱的元蛋白质组学分析在评估浮游细菌群落活动变化方面的敏感性、稳健性和可重复性。分类分析显示,65个细菌属的丰度发生了显著变化。特别是,黄杆菌属Candidatus proiliicoccus和Aurantivirga的蛋白质在后期样品中含量显著增加。这个全面的数据集突出了浮游植物繁殖期间细菌群落组成和代谢活动的半日变化,而每天一次的采样方法仍然无法检测到这些变化。
{"title":"Metaproteomic Dataset on Semi-Diurnal Variability of the Bacterioplankton Communities During a Spring Phytoplankton Bloom in the North Sea","authors":"Vaikhari Kale,&nbsp;Jürgen Bartel,&nbsp;Daniel Bartosik,&nbsp;Philip Berhard Lude,&nbsp;Chandni Sidhu,&nbsp;Hanno Teeling,&nbsp;Rudolf Amann,&nbsp;Thomas Schweder,&nbsp;Dörte Becher,&nbsp;Anke Trautwein-Schult","doi":"10.1002/pmic.70001","DOIUrl":"10.1002/pmic.70001","url":null,"abstract":"<p>Phytoplankton blooms create a substrate-rich environment that supports the growth of bacterial planktonic heterotrophs. Previously, we studied the dynamics of such bacterioplankton at a long-term ecological research site near the coast of Helgoland Island (North Sea) once a day. Here, we present a novel dataset (available under the PRIDE-ID: PXD055396) indicating significant differences at the protein level in a semi-diurnal analysis. Using metaproteomics, we studied changes in the free-living (0.2–3 µm) bacterial community that occurred between early (7 am) and late (9 pm) sampling over 3 days. The results highlight the sensitivity, robustness, and reproducibility of mass spectrometry-based metaproteomic analyses to assess changes in the activities of the bacterioplankton communities. Taxonomic analyses revealed significant changes in the abundance of 65 bacterial genera. Particularly, proteins from the flavobacterial genera <i>Candidatus</i> Prosiliicoccus and <i>Aurantivirga</i> were significantly more abundant in the late samples. This comprehensive dataset highlights semi-diurnal changes in bacterial community composition and metabolic activity during a phytoplankton bloom that would have remained undetected with a once-per-day sampling approach.</p>","PeriodicalId":224,"journal":{"name":"Proteomics","volume":"25 17-18","pages":"19-27"},"PeriodicalIF":3.9,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/epdf/10.1002/pmic.70001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144367639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sample Preparation for Multi-Omics Analysis: Considerations and Guidance for Identifying the Ideal Workflow 多组学分析的样品制备:确定理想工作流程的考虑和指导。
IF 3.9 4区 生物学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-06-23 DOI: 10.1002/pmic.13983
Breyer Woodland, Luke A. Farrell, Lana Brockbals, Maria Rezcallah, Aiden Brennan, Emily J. Sunnucks, Sam T. Gould, Aleksandra M. Stanczak, Matthew B. O'Rourke, Matthew P. Padula

Advances in methodologies and technologies over the past decade have led to an unprecedented depth of analysis of a cell's biomolecules, with entire genomes able to be sequenced in hours and up to 10,000 transcripts or ORF products (proteins) able to be quantified from a single cell. Methods for analysing individual omes are now optimised, reliable and robust but are often performed in isolation with other biomolecules considered contaminants. However, there is a growing body of systems biology studies that aim to study multiple omes from the same sample. This review details the current state of the “multi-omics” field, trying to define what the field is, the methodologies employed and the challenges facing researchers in this field. It also critically evaluates whether these approaches are “fit-for-purpose” and how the field needs to evolve to enhance our understanding of how biomolecules from distinct omes interact with one another to alter cellular phenotype in response to change.

在过去的十年中,方法和技术的进步导致了对细胞生物分子的前所未有的深度分析,整个基因组能够在几个小时内测序,并且能够从单个细胞中定量多达10,000个转录本或ORF产物(蛋白质)。分析单个基因组的方法现在已经过优化,可靠且稳健,但通常与其他被认为是污染物的生物分子分离进行。然而,越来越多的系统生物学研究旨在研究来自同一样本的多个基因组。本文详细介绍了“多组学”领域的现状,试图定义该领域是什么,所采用的方法以及该领域研究人员面临的挑战。它还批判性地评估了这些方法是否“适合目的”,以及该领域需要如何发展,以增强我们对来自不同基因组的生物分子如何相互作用以改变细胞表型以响应变化的理解。
{"title":"Sample Preparation for Multi-Omics Analysis: Considerations and Guidance for Identifying the Ideal Workflow","authors":"Breyer Woodland,&nbsp;Luke A. Farrell,&nbsp;Lana Brockbals,&nbsp;Maria Rezcallah,&nbsp;Aiden Brennan,&nbsp;Emily J. Sunnucks,&nbsp;Sam T. Gould,&nbsp;Aleksandra M. Stanczak,&nbsp;Matthew B. O'Rourke,&nbsp;Matthew P. Padula","doi":"10.1002/pmic.13983","DOIUrl":"10.1002/pmic.13983","url":null,"abstract":"<p>Advances in methodologies and technologies over the past decade have led to an unprecedented depth of analysis of a cell's biomolecules, with entire genomes able to be sequenced in hours and up to 10,000 transcripts or ORF products (proteins) able to be quantified from a single cell. Methods for analysing individual omes are now optimised, reliable and robust but are often performed in isolation with other biomolecules considered contaminants. However, there is a growing body of systems biology studies that aim to study multiple omes from the same sample. This review details the current state of the “multi-omics” field, trying to define what the field is, the methodologies employed and the challenges facing researchers in this field. It also critically evaluates whether these approaches are “fit-for-purpose” and how the field needs to evolve to enhance our understanding of how biomolecules from distinct omes interact with one another to alter cellular phenotype in response to change.</p>","PeriodicalId":224,"journal":{"name":"Proteomics","volume":"25 21-22","pages":"76-101"},"PeriodicalIF":3.9,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/epdf/10.1002/pmic.13983","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144367641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detergent Screening With Hybrid Detergents Increases Observable Number of Protein Identities in Bottom-Up Proteomics 混合洗涤剂筛选增加了自下而上蛋白质组学中可观察到的蛋白质特征数量。
IF 3.9 4区 生物学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-06-20 DOI: 10.1002/pmic.70003
Jan-Simon Behnke, Andreas Hentschel, Maximilian Wolf, Virginia Wycisk, Albert Sickmann, Robert S. Heyer, Leonhard H. Urner

Detergents are key reagents in bottom-up proteomics that create an apparent, yet underappreciated bias on observable proteomes. Maximizing the chemical diversity of detergents in parallelized screens is supposed to maximize observable proteomes if proteomics data sets of different detergents are combined. The aim of our work is to investigate the potential of fusing ionic and nonionic detergent headgroups into hybrid detergents for increasing the observable number of unique protein identities. Our data indicate that the solubilizing properties of hybrid detergents do not reflect an average of canonical detergents. The number of unique protein identities obtainable from an Escherichia coli screen increases from 1604 to 2169 when proteomics data sets from sodium dodecyl sulfate, dodecyltrimethylammonium bromide, dendritic triglycerol detergent, and related hybrid detergents are combined. Our data highlight the utility of cationic detergents and related hybrid detergents for enhancing observable proteomes. Detergent screening–based proteome reconstructions with canonical detergents and hybrid detergents present an interesting research direction towards improved proteome profiling applications.

洗涤剂是自下而上蛋白质组学的关键试剂,它对可观察到的蛋白质组学产生了明显但未被充分认识的偏见。如果将不同洗涤剂的蛋白质组学数据集结合起来,在并行筛选中最大化洗涤剂的化学多样性应该是最大化可观察到的蛋白质组学。我们工作的目的是研究将离子和非离子洗涤剂头群融合到混合洗涤剂中的潜力,以增加可观察到的独特蛋白质身份的数量。我们的数据表明,混合洗涤剂的增溶性能不反映标准洗涤剂的平均。当十二烷基硫酸钠、十二烷基三甲基溴化铵、树状甘油三酯洗涤剂和相关混合洗涤剂的蛋白质组学数据集相结合时,从大肠杆菌筛选中获得的独特蛋白质身份的数量从1604增加到2169。我们的数据强调了阳离子洗涤剂和相关混合洗涤剂对增强可观察到的蛋白质组的效用。基于洗涤剂筛选的典型洗涤剂和混合洗涤剂的蛋白质组重建为改进蛋白质组分析应用提供了一个有趣的研究方向。
{"title":"Detergent Screening With Hybrid Detergents Increases Observable Number of Protein Identities in Bottom-Up Proteomics","authors":"Jan-Simon Behnke,&nbsp;Andreas Hentschel,&nbsp;Maximilian Wolf,&nbsp;Virginia Wycisk,&nbsp;Albert Sickmann,&nbsp;Robert S. Heyer,&nbsp;Leonhard H. Urner","doi":"10.1002/pmic.70003","DOIUrl":"10.1002/pmic.70003","url":null,"abstract":"<p>Detergents are key reagents in bottom-up proteomics that create an apparent, yet underappreciated bias on observable proteomes. Maximizing the chemical diversity of detergents in parallelized screens is supposed to maximize observable proteomes if proteomics data sets of different detergents are combined. The aim of our work is to investigate the potential of fusing ionic and nonionic detergent headgroups into hybrid detergents for increasing the observable number of unique protein identities. Our data indicate that the solubilizing properties of hybrid detergents do not reflect an average of canonical detergents. The number of unique protein identities obtainable from an <i>Escherichia coli</i> screen increases from 1604 to 2169 when proteomics data sets from sodium dodecyl sulfate, dodecyltrimethylammonium bromide, dendritic triglycerol detergent, and related hybrid detergents are combined. Our data highlight the utility of cationic detergents and related hybrid detergents for enhancing observable proteomes. Detergent screening–based proteome reconstructions with canonical detergents and hybrid detergents present an interesting research direction towards improved proteome profiling applications.</p>","PeriodicalId":224,"journal":{"name":"Proteomics","volume":"25 15","pages":"6-12"},"PeriodicalIF":3.9,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329390/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144332220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancements in Ion Mobility-Based Diagnostics for Infectious Diseases 基于离子迁移率的传染病诊断研究进展
IF 3.9 4区 生物学 Q2 BIOCHEMICAL RESEARCH METHODS Pub Date : 2025-06-11 DOI: 10.1002/pmic.13976
Kimberly Y. Kartowikromo, Jessica S. Pizzo, Iffat Jerin, Ahmed M. Hamid

Infectious diseases remain a leading global health concern, requiring rapid, precise, and cost-effective diagnostic approaches. Traditional diagnostic methods, such as culture-based techniques, serological assays, and molecular diagnostics, often have sensitivity, specificity, and time efficiency limitations. The emergence of mass spectrometry (MS)-based technologies, particularly matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) MS, has revolutionized clinical microbiology by enabling rapid microbial identification. However, MALDI-TOF MS has limitations, such as its limited ability to differentiate closely related species and database constraints, necessitating the development of more advanced methodologies. Ion mobility (IM)-MS has emerged as a promising analytical tool that enhances pathogen identification by separating ions based on their size, mass, shape, and charge. IM-MS has demonstrated significant potential in clinical microbiology by improving the characterization of bacterial, viral, and fungal infections. This review discusses the significance of infectious disease diagnosis in public health and the impact of timely and accurate identification on treatment outcomes. In addition, it provides a comprehensive analysis of IM-MS, detailing its principles, integration with omics technologies and machine learning, and its applications in infectious disease diagnosis. The review also explores the advantages of IM-MS over conventional techniques, highlights key studies demonstrating its effectiveness, and discusses future perspectives for enhancing its role in clinical diagnostics, precision medicine, and public health surveillance.

传染病仍然是全球主要的健康问题,需要快速、精确和具有成本效益的诊断方法。传统的诊断方法,如基于培养的技术、血清学分析和分子诊断,通常具有敏感性、特异性和时间效率限制。基于质谱(MS)技术的出现,特别是基质辅助激光解吸电离飞行时间(MALDI-TOF)质谱,通过实现快速微生物鉴定,彻底改变了临床微生物学。然而,MALDI-TOF质谱存在局限性,例如区分密切相关物种的能力有限和数据库的限制,需要开发更先进的方法。离子迁移率(IM)-质谱已经成为一种很有前途的分析工具,通过根据它们的大小、质量、形状和电荷分离离子来增强病原体鉴定。IM-MS通过改善细菌、病毒和真菌感染的表征,在临床微生物学中显示出显著的潜力。本文综述了传染病诊断在公共卫生中的意义以及及时准确的诊断对治疗结果的影响。此外,它还提供了IM-MS的全面分析,详细介绍了它的原理,与组学技术和机器学习的集成,以及它在传染病诊断中的应用。本文还探讨了IM-MS相对于传统技术的优势,重点介绍了证明其有效性的关键研究,并讨论了增强其在临床诊断、精准医学和公共卫生监测方面作用的未来前景。
{"title":"Advancements in Ion Mobility-Based Diagnostics for Infectious Diseases","authors":"Kimberly Y. Kartowikromo,&nbsp;Jessica S. Pizzo,&nbsp;Iffat Jerin,&nbsp;Ahmed M. Hamid","doi":"10.1002/pmic.13976","DOIUrl":"10.1002/pmic.13976","url":null,"abstract":"<div>\u0000 \u0000 <p>Infectious diseases remain a leading global health concern, requiring rapid, precise, and cost-effective diagnostic approaches. Traditional diagnostic methods, such as culture-based techniques, serological assays, and molecular diagnostics, often have sensitivity, specificity, and time efficiency limitations. The emergence of mass spectrometry (MS)-based technologies, particularly matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) MS, has revolutionized clinical microbiology by enabling rapid microbial identification. However, MALDI-TOF MS has limitations, such as its limited ability to differentiate closely related species and database constraints, necessitating the development of more advanced methodologies. Ion mobility (IM)-MS has emerged as a promising analytical tool that enhances pathogen identification by separating ions based on their size, mass, shape, and charge. IM-MS has demonstrated significant potential in clinical microbiology by improving the characterization of bacterial, viral, and fungal infections. This review discusses the significance of infectious disease diagnosis in public health and the impact of timely and accurate identification on treatment outcomes. In addition, it provides a comprehensive analysis of IM-MS, detailing its principles, integration with omics technologies and machine learning, and its applications in infectious disease diagnosis. The review also explores the advantages of IM-MS over conventional techniques, highlights key studies demonstrating its effectiveness, and discusses future perspectives for enhancing its role in clinical diagnostics, precision medicine, and public health surveillance.</p>\u0000 </div>","PeriodicalId":224,"journal":{"name":"Proteomics","volume":"25 14","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144264970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Proteomics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1